Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved.

Anker SD, Butler J, Usman MS, Filippatos G, Ferreira JP, Bocchi E, Böhm M, Rocca HPB, Choi DJ, Chopra V, Chuquiure E, Giannetti N, Gomez-Mesa JE, Janssens S, Januzzi JL, González-Juanatey JR, Merkely B, Nicholls SJ, Perrone SV, Piña IL, Ponikowski P, Senni M, Sim D, Spinar J, Squire I, Taddei S, Tsutsui H, Verma S, Vinereanu D, Zhang J, Iwata T, Schnee JM, Brueckmann M, Pocock SJ, Zannad F

Open source

DOI: 10.1038/s41591-022-02041-5
Published: 2022 Dec
Container: Nature medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41591-022-02041-5,
  title = {Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved.},
  author = {Anker SD and Butler J and Usman MS and Filippatos G and Ferreira JP and Bocchi E and Böhm M and Rocca HPB and Choi DJ and Chopra V and Chuquiure E and Giannetti N and Gomez-Mesa JE and Janssens S and Januzzi JL and González-Juanatey JR and Merkely B and Nicholls SJ and Perrone SV and Piña IL and Ponikowski P and Senni M and Sim D and Spinar J and Squire I and Taddei S and Tsutsui H and Verma S and Vinereanu D and Zhang J and Iwata T and Schnee JM and Brueckmann M and Pocock SJ and Zannad F},
  year = {2022},
  journal = {Nature medicine},
  doi = {10.1038/s41591-022-02041-5},
  url = {https://doi.org/10.1038/s41591-022-02041-5}
}

RIS

TY  - JOUR
TI  - Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved.
AU  - Anker SD
AU  - Butler J
AU  - Usman MS
AU  - Filippatos G
AU  - Ferreira JP
AU  - Bocchi E
AU  - Böhm M
AU  - Rocca HPB
AU  - Choi DJ
AU  - Chopra V
AU  - Chuquiure E
AU  - Giannetti N
AU  - Gomez-Mesa JE
AU  - Janssens S
AU  - Januzzi JL
AU  - González-Juanatey JR
AU  - Merkely B
AU  - Nicholls SJ
AU  - Perrone SV
AU  - Piña IL
AU  - Ponikowski P
AU  - Senni M
AU  - Sim D
AU  - Spinar J
AU  - Squire I
AU  - Taddei S
AU  - Tsutsui H
AU  - Verma S
AU  - Vinereanu D
AU  - Zhang J
AU  - Iwata T
AU  - Schnee JM
AU  - Brueckmann M
AU  - Pocock SJ
AU  - Zannad F
PY  - 2022
JO  - Nature medicine
DO  - 10.1038/s41591-022-02041-5
UR  - https://doi.org/10.1038/s41591-022-02041-5
ER  -

APA

SD, A., J, B., MS, U., G, F., JP, F., E, B., M, B., HPB, R., DJ, C., V, C., E, C., N, G., JE, G., S, J., JL, J., JR, G., B, M., SJ, N., SV, P., IL, P., P, P., M, S., D, S., J, S., I, S., S, T., H, T., S, V., D, V., J, Z., T, I., JM, S., M, B., SJ, P., & F, Z. (2022). Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved.. Nature medicine. https://doi.org/10.1038/s41591-022-02041-5

Source records

pubmed · retrieved 2026-09-26T23:00:58.316Z
europe-pmc · retrieved 2026-09-26T23:00:58.318Z
hal · retrieved 2026-09-26T23:00:58.332Z